Ritu Lal
individual
About
Ritu Lal, PhD, is a biotech executive and drug-development specialist who serves as CEO and co-founder of GEn1E Lifesciences, a Palo Alto techbio company focused on immunomodulatory therapies for inflammatory and age-related diseases. Public bios state she has more than 20 years of biotech/pharma experience, has led preclinical and clinical development programs, and sits on the Advisory Committee of Ascend BioVentures. She is a University of Maryland School of Pharmacy alumna and also earned a master’s in management from Stanford’s MSx program.
Areas of interest
biotechnologypharmacologyclinical developmentdrug discoveryimmunologyinflammatory diseasesage-related diseasesAI drug discoveryrare diseasesoncologypulmonary disease